Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Mona Amini‐Adle"'
Autor:
Samy Belkaïd, MD, Mona Amini-Adle, MD
Publikováno v:
JAAD Case Reports, Vol 49, Iss , Pp 88-90 (2024)
Externí odkaz:
https://doaj.org/article/252ec49aa9bf451b954911fe12b09fe7
Autor:
Stéphane Dalle, Estelle Verronese, Axelle N’Kodia, Christine Bardin, Céline Rodriguez, Thibault Andrieu, Anais Eberhardt, Gabriel Chemin, Uzma Hasan, Myrtille Le-Bouar, Julie Caramel, Mona Amini-Adle, Nathalie Bendriss-Vermare, Bertrand Dubois, Christophe Caux, Christine Ménétrier-Caux
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
The need for reliable biomarkers to predict clinical benefit from anti-PD1 treatment in metastatic melanoma (MM) patients remains unmet. Several parameters have been considered in the tumor environment or the blood, but none has yet achieved sufficie
Externí odkaz:
https://doaj.org/article/d836ec6499ae4687ab74ec8786ab28fa
Autor:
François Skowron, Stéphane Mouret, Arnaud Seigneurin, Henri Montaudié, Eve Maubec, Florent Grange, Gaelle Quereux, Philippe Célérier, Mona Amini‐Adle, Sophie Dalac‐Rat, Julie De Quatrebarbes, Ouidad Zehou, Abed Safia, Philippe Muller, Philippe Modiano, Laurent Misery, Noemie Litrowski, Florence Brunet‐Possenti, Laurent Mortier, Guido Bens, Alice Hervieu, Nicolas Leduc, Thomas Jouary, Candice Lesage, Nathalie Beneton, Yannick Le Corre, Lionnel Geoffrois, Domitille Thomas‐Beaulieu, Ewa Hainaut, Marie‐Thérèse Leccia
Publikováno v:
JEADV Clinical Practice, Vol 2, Iss 3, Pp 638-642 (2023)
Externí odkaz:
https://doaj.org/article/ea8ac9a2758d4c07a6dd91cc17cbe831
Autor:
Jean-Matthieu L’Orphelin, Sara Le Naour, Stephane Dalle, Emilie Varey, Alain Dupuy, Henry Montaudie, Candice Lesage, Laurent Mortier, Marie-Thérèse Leccia, Philippe Celerier, François Skowron, Nicolas Meyer, Eve Maubec, Mona Amini-Adle, Sophie Dalac-Rat, Caroline Dutriaux, Amir Khammari, Anne Dompmartin, Brigitte Dreno
Publikováno v:
European Journal of Dermatology. 32:691-697
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5daf38aca57e0ed8bce6ec2db43bb14a
https://doi.org/10.1684/ejd.2022.4357
https://doi.org/10.1684/ejd.2022.4357
Autor:
Céleste Lebbe, Samia Mourah, Maxime Battistella, Keyvan Rezai, Samuel Huguet, Annick Tibi, Didier Bouton, Paul Vilquin, Zineb Ghrieb, Fanélie Jouenne, Aurélie Sadoux, Coralie Reger de Moura, Caroline Dutriaux, Mona Amini-Adle, Julie Delyon, Barouyr Baroudjian, Marc Pracht, Laetitia Da Meda, Thierry Lesimple, Matthieu Resche-Rigon, Baptiste Louveau
Figure S2. (A) Change in the tumor burden from baseline over time according to RECIST for all the included patients. The tumor burden was measured as the sum of the longest diameters of target lesions. Each line represents a patient. (B) Kaplan-Meier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::272e3c9431d2fe17ad4e23f5c0092460
https://doi.org/10.1158/1078-0432.22480554
https://doi.org/10.1158/1078-0432.22480554
Autor:
Céleste Lebbe, Samia Mourah, Maxime Battistella, Keyvan Rezai, Samuel Huguet, Annick Tibi, Didier Bouton, Paul Vilquin, Zineb Ghrieb, Fanélie Jouenne, Aurélie Sadoux, Coralie Reger de Moura, Caroline Dutriaux, Mona Amini-Adle, Julie Delyon, Barouyr Baroudjian, Marc Pracht, Laetitia Da Meda, Thierry Lesimple, Matthieu Resche-Rigon, Baptiste Louveau
Purpose:In BRAFV600MUT metastatic melanoma, cyclin D–CDK4/6–INK4–Rb pathway alterations are involved in resistance to MAPK inhibitors, suggesting a clinical benefit of cyclin-dependent kinase 4 (CDK4) inhibitors. In this phase I–II study, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3af0eef26415c8819e4c5b5543de08
https://doi.org/10.1158/1078-0432.c.6530460
https://doi.org/10.1158/1078-0432.c.6530460
Autor:
Céleste Lebbe, Samia Mourah, Maxime Battistella, Keyvan Rezai, Samuel Huguet, Annick Tibi, Didier Bouton, Paul Vilquin, Zineb Ghrieb, Fanélie Jouenne, Aurélie Sadoux, Coralie Reger de Moura, Caroline Dutriaux, Mona Amini-Adle, Julie Delyon, Barouyr Baroudjian, Marc Pracht, Laetitia Da Meda, Thierry Lesimple, Matthieu Resche-Rigon, Baptiste Louveau
Supplementary Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b0cb79529fe16cf7b7f5ecfa443c579
https://doi.org/10.1158/1078-0432.22480545
https://doi.org/10.1158/1078-0432.22480545
Autor:
Céleste Lebbe, Samia Mourah, Maxime Battistella, Keyvan Rezai, Samuel Huguet, Annick Tibi, Didier Bouton, Paul Vilquin, Zineb Ghrieb, Fanélie Jouenne, Aurélie Sadoux, Coralie Reger de Moura, Caroline Dutriaux, Mona Amini-Adle, Julie Delyon, Barouyr Baroudjian, Marc Pracht, Laetitia Da Meda, Thierry Lesimple, Matthieu Resche-Rigon, Baptiste Louveau
Tables S1, S2, S3, S4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0565bed1a58abc520acba9f808af10fa
https://doi.org/10.1158/1078-0432.22480542
https://doi.org/10.1158/1078-0432.22480542
Autor:
Adeline, Pêtre, Pascal, Pommier, Tristan, Brahmi, Sylvie, Chabaud, Sophie, King, Jérôme, Fayette, Eve-Marie, Neidhart, Mona, Amini-Adle
Publikováno v:
Radiotherapy and Oncology. 168:53-60
Indications of adjuvant radiotherapy (RT) for high-risk cutaneous squamous cell carcinoma (cSCC) are not clearly defined. We aimed to identify factors predicting relapse in cSCC patients treated with surgery or RT alone and to assess in which clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::907d6cb0ca82ca66f13018f799417c50
https://doi.org/10.1016/j.radonc.2022.01.015
https://doi.org/10.1016/j.radonc.2022.01.015
Autor:
Patrick Combemale, Zuzana Bencokova, Clément Devic, Stéphane Pinson, Larry Bodgi, Jacques Balosso, Nicolas Foray, Jean-Thomas Bachelet, Mélanie L. Ferlazzo, Michel Bourguignon, Mona Amini-Adle, Steven Franck Burlet, Adeline Granzotto, Joëlle Al-Choboq, Laurène Sonzogni
Publikováno v:
Molecular Neurobiology. 59:556-573
Neurofibromatosis type 1 (NF1) is a disease characterized by high occurrence of benign and malignant brain tumours and caused by mutations of the neurofibromin protein. While there is an increasing evidence that NF1 is associated with radiosensitivit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69b37b0289dc91c5d007bab97bcde007
https://doi.org/10.1007/s12035-021-02615-3
https://doi.org/10.1007/s12035-021-02615-3